| |
|
|
|
|
|
|
|||
|
Blood, 20 August 2009, Vol. 114, No. 8, pp. 1689-1695. Prepublished online as a Blood First Edition Paper on June 17, 2009; DOI 10.1182/blood-2008-12-194696.
Submitted December 15, 2008
Department of Hematology, Toranomon Hospital, Tokyo, Japan * Corresponding author; email: nuchida{at}toranomon.gr.jp.
Delayed engraftment or graft failure is one of the major complications following cord blood transplantation (CBT). In order to investigate factors impacting engraftment, we conducted a retrospective analysis of adult patients who underwent reduced-intensity (RI)-CBT at our institute, in which preparative regimens were mainly consisted of fludarabine, melphalan, and total body irradiation with graft-versus-host (GVH) disease (GVHD) prophylaxis using single calcineurin inhibitors. Among 152 evaluable patients, the cumulative incidence of neutrophil engraftment was 89%. High total nucleated cell and CD34+ cell dose were associated with the faster speed and higher probability of engraftment. In addition, the degree of human leukocyte antigen (HLA) mismatch in the GVH direction was inversely associated with engraftment kinetics, whereas no statistically significant association was observed with the degree of HLA mismatch in the host-versus-graft (HVG) direction. Similarly, the number of HLA class I antigens mismatch in the GVH direction, but not in the HVG direction, showed a negative correlation with engraftment kinetics. HLA disparity did not have significant impact on the development of GVHD or survival. This result indicates the significant role of HLA disparity in the GVH direction in the successful engraftment, raising the novel mechanism responsible for graft failure in CBT.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||